Population
Patients with prosthetic valve endocarditis (PVE)
Design
Review
Key result
Prosthetic valve endocarditis has a high incidence in the first year after valve replacement and requires similar antimicrobial treatment to native valve endocarditis despite larger vegetations.
Authors
Loading...
Highlights elevated early risk after valve replacement; supports similar regimens for prosthetic and native valve endocarditis but requires prospective confirmation.
Prosthetic valve endocarditis carries high mortality and morbidity, with distinct microbiological profiles for healthcare-associated versus community-acquired infections, and requires consideration of larger vegetations during antimicrobial therapy.
M.Phanindranath et al. (2014) conducted a review in Prosthetic valve endocarditis. Prosthetic valve endocarditis has a high incidence in the first year after valve replacement and requires similar antimicrobial treatment to native valve endocarditis despite larger vegetations.